跳至主要内容
临床试验/NCT02789891
NCT02789891Unknown不适用

Randomized Controlled Trials on Laparoscopic No. 14v Lymph Node Dissection for Advanced Lower Third Gastric Cancer

Fujian Medical University0 个研究点目标入组 326 人开始时间: 2016年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
326
主要终点
3-year disease overall survival rate

研究概览

简要总结

The purpose of this study is to explore the short-term, long-term and oncological outcomes of laparoscopic No. 14v lymph node dissection in advanced lower third gastric cancer.

详细描述

A prospective randomized comparison of laparoscopic No. 14v lymph node dissection in advanced lower third gastric cancer will be performed, to evaluate the short-term, long-term and oncological outcomes. The evaluation parameters are perioperative clinical efficacy, postoperative life quality, immune function and 3-year survival and recurrence rates.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
10 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 18 to 75 years
  • Primary lower third gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy
  • cT2-4a, N0-3, M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition
  • No distant metastasis is observed. And the spleen, pancreas or other adjacent organs are not involved by the tumor.
  • Performance status of 0 or 1 on Eastern Cooperative Oncology Group scale (ECOG)
  • American Society of Anesthesiology score (ASA) class I, II, or III
  • Written informed consent

排除标准

  • Women during pregnancy or breast-feeding
  • Severe mental disorder
  • History of previous upper abdominal surgery (except laparoscopic cholecystectomy)
  • History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection
  • Enlarged or bulky regional lymph node envelop important vessels
  • History of other malignant disease within past five years
  • History of previous neoadjuvant chemotherapy or radiotherapy
  • History of unstable angina or myocardial infarction within past six months
  • History of cerebrovascular accident within past six months
  • History of continuous systematic administration of corticosteroids within one month
  • Requirement of simultaneous surgery for other disease
  • Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer
  • FEV1<50% of predicted values

结局指标

主要结局

3-year disease overall survival rate

时间窗: 36 months

次要结局

  • No.14v Lymph node metastasis rate(10 days)
  • Time to soft diet(10 days)
  • 3-year free survival rate(36 months)
  • The variation of weight(12 months)
  • Time to first liquid diet(10 days)
  • Morbidity and mortality(30 days; 36 months)
  • 3-year recurrence pattern(36 months)
  • Duration of hospital stay(10 days)
  • The variation of albumin(12 months)
  • The values of white blood cell count(7 days)
  • The values of hemoglobin(7 days)
  • Time to first ambulation(10 days)
  • The number of lymph node dissection(10day)
  • The daily highest body temperature(7 day)
  • Time to first flatus(10 days)
  • The amount of abdominal drainage(10 days)
  • Intraoperative lymph node dissection time(1 day)
  • The amount of use of titanium clip(1 day)
  • The rate of conversion to laparotomy(1 day)
  • The variation of cholesterol(12 months)
  • The results of endoscopy(12 months)
  • Visual Analog Score for pain(7 days)
  • EORTC QLQ-C30 and QLQ - STO22(Time Frame: 36 months)
  • Blood transfusion(10 days)
  • The number of positive lymph nodes(1 day)
  • Intraoperative blood loss(1 day)
  • Intraoperative injury(1 day)
  • The values of C-reactive protein(7 days)
  • The values of relevant immune cytokines(7 days)
  • The values of prealbumin(7 days)

研究者

发起方
Fujian Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chang-Ming Huang, Prof.

Director, Principal Investigator, Clinical Professor

Fujian Medical University

相似试验

Randomized Controlled Trials on Laparoscopic No. 14v... | 临床试验